Indium (111In) imciromab

From Wikipedia, the free encyclopedia
Indium (111In) imciromab?
Monoclonal antibody
Type Whole antibody
Source Mouse
Target cardiac myosin
Clinical data
Trade names Myoscint
Legal status withdrawn
Identifiers
CAS number 126132-83-0 N (imciromab)
ATC code V09GX02
Chemical data
Formula ?
 N (what is this?)  (verify)

Indium (111In) imciromab (trade name Myoscint) is a mouse monoclonal antibody labelled with the radioisotope Indium-111.[1] It was used for cardiac imaging, but withdrawn in 1993.[2]

See also

References

  1. ↑ WHO Drug Information
  2. ↑ DiagnosticImaging.com: Centocor withdraws imaging agent applications
Central nervous system
Skeletal system
Renal
  • 123I (Sodium iodohippurate)
Hepatic/reticuloendothelial
Respiratory system
  • 133Xe
  • 81mKr
Cardiovascular system
Inflammation/infection
Tumor
Adrenal cortex
Radionuclides
(including tracers)
Monoclonals for bone, musculoskeletal, circulatory, and neurologic systems
Bone ("-os-", "-s(o)-")
Human ("-osu-")
Humanized ("-sozu-")
Musculoskeletal ("-mul-")
Human ("-mulu-")
Circulatory ("-c(i[r])-")
Human ("-ciru-")
Mouse ("-ciro-")
Chimeric ("-cixi-")
Humanized ("-cizu-")
Neurologic ("-ne(u)(r)-")
Human ("-neru-")
Humanized ("-nezu-"/"-neuzu-")
Angiogenesis inhibitor ("-anibi-")
Humanized ("-anibizu-")


This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.